Thomas Catinazzo Net Worth & Insider Trades
Thomas Catinazzo - Chief Financial Officer, Relay Therapeutics, Inc
What is Thomas Catinazzo's Net Worth?
The current estimated net worth of Relay Therapeutics, Inc's Chief Financial Officer, Thomas Catinazzo, is estimated to be about $4.8M . Thomas Catinazzo owns about 150,482 units of Relay Therapeutics, Inc common stock. In the last 3 years at Relay Therapeutics, Inc, Thomas Catinazzo has sold an estimated value of $4.48M worth.
What is Thomas Catinazzo's Past Insider Trading?
Thomas Catinazzo's largest purchase order was 26,257 units , worth over $108.18K on September 8, 2022. Thomas Catinazzo's largest sale order was 22,500 units , worth over $796.5K on November 16, 2021. In total, Thomas Catinazzo has made about 21 transactions over 3 years of their time at Relay Therapeutics, Inc. Thomas Catinazzo usually trades in September, with the busiest year in 2022. The most recent transaction was a sale order of 864 units , worth over $18.63K on January 31, 2023.
Thomas Catinazzo
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Thomas Catinazzo's' Mailing Address?
- Mailing address is C/o Relay Therapeutics, Inc. 399 Binney Street Cambridge MA 02139 MA
Relay Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Sanjiv K. Patel, M.D. | 2020 | $585,000 | $7,965,341 | $402,188 | - | $8,952,529 |
| Sanjiv K. Patel, M.D. | 2019 | $585,000 | $2,590,671 | $353,925 | - | $3,529,596 |
| Donald Bergstrom M.D., Ph.D. | 2020 | $440,000 | $1,339,104 | $220,000 | $9,816 | $2,008,920 |
| Donald Bergstrom M.D., Ph.D. | 2019 | $406,850 | $330,652 | $179,014 | - | $916,516 |
| Brian R. Adams | 2020 | $390,000 | $714,193 | $170,625 | $7,428 | $1,282,246 |
| Brian R. Adams | 2019 | $356,213 | $165,326 | $97,958 | - | $619,497 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1812364/000156459021018016/rlay-def14a_20210519.htm
What are Relay Therapeutics, Inc's Past Insider Trades?
Relay Therapeutics, Inc's most recent insider trade came on January 31, 2023 by Peter Rahmer who sold 740 units worth $15.95K . In the last 3 years, insiders at Relay Therapeutics, Inc have sold an estimated value of $250M and bought an estimated value of $5.06M worth of shares. Insider trading is most common in January, with the busiest year in 2022. The most active traders at the company are Donald Bergstrom, President, Brian Adams, Chief Legal Officer, and Thomas Catinazzo, Chief Financial Officer .
Relay Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||